Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$239.25 - $280.76 $1.72 Million - $2.02 Million
7,200 Added 39.56%
25,400 $7.06 Million
Q2 2024

Aug 14, 2024

BUY
$235.51 - $267.98 $2.64 Million - $3 Million
11,200 Added 160.0%
18,200 $4.55 Million
Q1 2024

May 15, 2024

BUY
$224.58 - $256.19 $1.48 Million - $1.69 Million
6,600 Added 1650.0%
7,000 $1.75 Million
Q4 2023

Feb 14, 2024

BUY
$185.1 - $233.13 $74,040 - $93,252
400 New
400 $92,000
Q1 2022

May 16, 2022

BUY
$257.27 - $315.76 $308,724 - $378,912
1,200 New
1,200 $352,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $171B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.